BSE Live
Apr 10, 16:01Prev. Close
730.05
Open Price
738.65
Bid Price (Qty.)
721.00 (1)
Offer Price (Qty.)
778.50 (20)
NSE Live
Apr 10, 15:50Prev. Close
725.80
Open Price
736.70
Bid Price (Qty.)
732.00 (97)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Albert David (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Total Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Reserves and Surplus | 57.34 | 50.06 | 44.87 | 41.40 | 30.21 | |
| Total Reserves and Surplus | 57.34 | 50.06 | 44.87 | 41.40 | 30.21 | |
| Total Shareholders Funds | 63.05 | 55.77 | 50.58 | 47.11 | 35.92 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 27.08 | 34.62 | 37.30 | 13.88 | 13.93 | |
| Deferred Tax Liabilities [Net] | 7.18 | 6.88 | 6.50 | 4.16 | 1.35 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 34.26 | 41.50 | 43.79 | 18.03 | 15.28 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 25.27 | 20.71 | 18.78 | 21.35 | 13.25 | |
| Trade Payables | 23.54 | 9.00 | 7.85 | 10.87 | 8.05 | |
| Other Current Liabilities | 27.46 | 25.69 | 20.53 | 20.24 | 15.39 | |
| Short Term Provisions | 11.41 | 8.71 | 8.10 | 6.33 | 3.34 | |
| Total Current Liabilities | 87.68 | 64.11 | 55.26 | 58.80 | 40.04 | |
| Total Capital And Liabilities | 184.99 | 161.38 | 149.64 | 123.95 | 91.24 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 76.21 | 71.83 | 73.02 | 43.69 | 30.91 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 1.00 | 0.61 | 0.07 | 12.00 | 5.75 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 77.22 | 72.44 | 73.09 | 55.69 | 36.66 | |
| Non-Current Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Deferred Tax Assets [Net] | 2.38 | 2.06 | 1.95 | 0.76 | 0.69 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 79.60 | 74.51 | 75.05 | 56.46 | 37.36 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 31.46 | 34.13 | 37.32 | 34.31 | 23.94 | |
| Trade Receivables | 26.16 | 21.41 | 18.59 | 17.54 | 11.37 | |
| Cash And Cash Equivalents | 15.05 | 16.22 | 7.08 | 5.03 | 11.39 | |
| Short Term Loans And Advances | 32.72 | 15.10 | 11.60 | 10.62 | 7.18 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 105.38 | 86.87 | 74.58 | 67.49 | 53.88 | |
| Total Assets | 184.99 | 161.38 | 149.64 | 123.95 | 91.24 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 9.24 | 8.92 | 9.86 | 15.78 | 6.45 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 21.08 | 23.08 | 19.92 | 19.65 | 11.95 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 9.06 | 4.52 | 8.59 | 1.18 | 11.19 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 1.65 | 1.49 | 1.67 | 1.09 | 1.14 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 17.27 | 14.69 | 13.05 | 12.07 | 12.96 | |
| Other Earnings | 0.99 | 0.82 | 1.17 | 1.08 | 1.04 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
13.04.2026
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth